论文部分内容阅读
1988年以来,我们共收治上睑板腺癌患者9例,均施行下睑板结膜瓣再造上睑术,随访2～5年,效果满意。现报告如下。 临床资料:本组男6例,女3例;年龄44～66岁,平均56岁。右眼5例,左眼4例;肿瘤最大11mm×7mm×8mm,最小5mm×4mm×2mm,均未侵犯上穹窿部结膜。肿瘤切除后,上睑缺损较大,其中眼睑缺损1/2者3例,2/3者5例,全眼睑缺损者1例。病理分型为分化型4例,鳞癌型4例,基底细胞型1例。临床分期为Ⅰ期5例,Ⅱ期3例,Ⅲ期1例。 手术方法:在病变侧上睑板上缘的提上睑肌肌腱处预置2～3针缝线,切除包括肿瘤在内的睑板与结膜,向上分离暴露提上睑肌,分别垂直切开缺损剩下部分的内、外侧缘,即得提上睑肌结膜瓣。沿下睑板沟切开结膜及睑板,使之与上睑缺损等长,充分分离至下穹窿部,做一个与上睑缺损相对应的睑板结
Since 1988, we treated a total of 9 patients with upper meibomian gland cancer, were under the implementation of the lower tarsal conjunctiva flap reconstruction surgery, follow-up of 2 to 5 years, with satisfactory results. The report is as follows. Clinical data: The group of 6 males and 3 females; aged 44 to 66 years, mean 56 years. The right eye in 5 cases, the left eye in 4 cases; the largest tumor 11mm × 7mm × 8mm, the smallest 5mm × 4mm × 2mm, did not infringe on the fornix conjunctiva. After tumor resection, the eyelid defect was larger, including 3 cases of eyelid defect 1/2, 5 cases of 2/3, and 1 case of eyelid defect. Pathological type of differentiation in 4 cases, 4 cases of squamous cell carcinoma, basal cell type in 1 case. The clinical stage was stage Ⅰ in 5 cases, stage Ⅱ in 3 cases and stage Ⅲ in 1 case. Surgical methods: on the lesion side of the upper tarsal levator tendon Department pre-placed 2 to 3 stitches, including removal of the tarsal and conjunctiva, including the tumor, the upward separation of exposure levator muscle, respectively, vertical incision Defect the remaining part of the medial and lateral margin, that is, mention levator muscle conjunctival flap. Along the lower tarsal groove incision conjunctiva and tarsus, so that with the eyelid defect as long, fully separated into the lower fornix, to make a blepharocal junction corresponding with the upper eyelid defect